Form 4: TransMedics Group Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Tamer I. Khayal, Chief Commercial Officer of TransMedics Group, sold 2,407 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Tamer I. Khayal, the Chief Commercial Officer of TransMedics Group, Inc. (TMDX), sold 2,407 shares of common stock on March 3, 2025.
- The shares were sold at a price of $76.43 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Khayal directly owns 36,042 shares of TransMedics Group, Inc.
Sentiment
Score: 5
Explanation: The Form 4 filing itself is neutral. It simply reports a transaction. The sale is related to tax obligations, which is a normal part of executive compensation.
Industry Context
Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the transaction (sale of shares) |
| 03/05/2025 | Date of signature on the Form 4 filing |
Keywords
TransMedics Group, Tamer I. Khayal, Form 4, share sale, restricted stock units, tax withholding, TMDX, Chief Commercial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.